LifeArc | PharmaTimes https://pharmatimes.com in-depth news, features and insights for the pharmaceutical and healthcare sectors Wed, 23 Apr 2025 11:26:44 +0000 en-US hourly 1 https://pharmatimes.com/wp-content/uploads/2023/11/PT-icon-150x150.png LifeArc | PharmaTimes https://pharmatimes.com 32 32 232894315 UCL researchers launch congenital muscular dystrophy research programme https://pharmatimes.com/news/ucl-researchers-launch-congenital-muscular-dystrophy-research-programme/ Wed, 23 Apr 2025 11:16:58 +0000 https://pharmatimes.com/?p=103139 The university has been awarded a £1m grant from LifeArc and Muscular Dystrophy UK

]]> 103139 New drug trial to investigate treatment for patients with bronchiectasis https://pharmatimes.com/news/new-drug-trial-to-investigate-treatment-for-patients-with-bronchiectasis/ Thu, 22 Aug 2024 12:14:26 +0000 https://pharmatimes.com/?p=102230 200,000 people in the UK have what is considered a ‘hidden’ lung condition

]]> 102230 Cystic fibrosis drug improves outcomes in severe COVID-19 pneumonia https://pharmatimes.com/news/cystic-fibrosis-drug-improves-outcomes-in-severe-covid-19-pneumonia/ Thu, 18 Jul 2024 09:59:00 +0000 https://pharmatimes.com/?p=102076 Genentech’s Pulmozyme could also treat other respiratory infections and conditions

]]> 102076 UK DRI and NHS collaborate on digitally enabled dementia care platform https://pharmatimes.com/news/uk-dri-and-nhs-to-collaborate-on-digitally-enabled-dementia-care-minder-platform/ Wed, 10 Jul 2024 10:06:40 +0000 https://pharmatimes.com/?p=102028 Around one in five dementia hospitalisations are due to potentially preventable causes

]]> 102028 LifeArc funds new projects to address and prevent global threat of dengue fever https://pharmatimes.com/news/lifearc-funds-new-projects-to-address-and-prevent-global-threat-of-dengue-fever/ Thu, 13 Jun 2024 10:14:17 +0000 https://pharmatimes.com/?p=101834 The mosquito-borne viral disease is responsible for an estimated 390 million cases globally

]]> 101834 New paediatric blood test to prevent sudden death from hereditary heart condition https://pharmatimes.com/news/new-paediatric-blood-test-to-prevent-sudden-death-from-hereditary-heart-condition/ Mon, 10 Jun 2024 10:14:26 +0000 https://pharmatimes.com/?p=101818 Hypertrophic cardiomyopathy is a rare condition that affects up to 1,000 children in the UK

]]> 101818 LifeArc and ALS TDI announce partnership to develop new clinical tools for ALS and MND https://pharmatimes.com/news/lifearc-and-als-tdi-announce-partnership-to-develop-new-clinical-tools-for-als-and-mnd/ Tue, 28 May 2024 10:22:07 +0000 https://pharmatimes.com/?p=101764 The project will validate two minimally invasive biomarkers for ALS: MMP-9 and TIMP-1

]]> 101764 Researchers combine herpes virus with cancer vaccine to treat brain cancer in children https://pharmatimes.com/news/researchers-combine-herpes-virus-with-cancer-vaccine-to-treat-brain-cancer-in-children/ Thu, 23 May 2024 10:45:55 +0000 https://pharmatimes.com/?p=101707 High-grade gliomas are rare, malignant tumours which account for up to 12% of all childhood brain tumours

]]> 101707 LifeArc provides £750,000 fund for clinical trial to treat neuroferritinopathy https://pharmatimes.com/news/lifearc-provides-750000-fund-for-clinical-trial-to-treat-patients-with-neuroferritinopathy/ Wed, 27 Mar 2024 11:25:18 +0000 https://pharmatimes.com/?p=101343 The progressive and incurable brain disorder currently affects approximately 100 patients worldwide

]]> 101343 LifeArc and UKDRI invest £14.5m into neurodegeneration research https://pharmatimes.com/news/lifearc_and_ukdri_invest_14-5m_into_neurodegeneration_research_1503838/ Thu, 16 Nov 2023 12:18:00 +0000 https://pharmatimes.com/uncategorized/lifearc_and_ukdri_invest_14-5m_into_neurodegeneration_research_1503838/ The funding will be used to develop new diagnostic tests, treatments and devices

]]> 100175